Dova Pharmaceuticals
Dova Pharmaceuticals focused on acquiring, developing and commercializing drug candidates.
Launch date
Employees
Market cap
-
Enterprise valuation
€832m (Public information from Sep 2019)
Durham North Carolina (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Seed | |
N/A | Post IPO Equity | ||
* | $915m Valuation: $915m | Acquisition | |
| Total Funding | - | ||
Related Content
Recent News about Dova Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.